We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
We are excited to share that Annette Favorite, Senior Vice President and Chief Human Resources Officer at West, has been recognized as a 2018 Women of Distinction Winner by the Philadelphia Business Journal. She was recognized at the Women of Distinction Awards Dinner, held at the Sheraton Philadelphia Society Hill Hotel in Philadelphia, Pennsylvania, on November 15, 2018.
The Philadelphia Business Journal’s Women of Distinction Award recognizes influential business women in the broader Philadelphia region who have had a significant impact in their place of business, have made a difference in their communities, are leaving a mark on Philadelphia business, and who are committed to advancing women in the workplace. This year, they received a record 300 nominations, and a panel of judges selected 35 women for the 2018 Women of Distinction class.
“I feel lucky to be able to come to work each day at West, knowing I can make a difference by building teams and fostering a culture that enables our people to bring our products to patients across the globe to impact the delivery of healthcare in such a meaningful way,” said Annette. “It is humbling to be named a ‘Woman of Distinction’ for this work, and I am honored to be one among this group of talented women.”
As Senior Vice President & Chief Human Resources (HR) Officer, Annette is charged with leading organizational strategy and elevating team performance through innovative HR programs at West. In addition to leading this team, Annette serves as the President of the Herman O. West Foundation, which supports West employees through scholarship, matching gift and employee relief programs. Prior to joining West, Ms. Favorite spent more than 25 years at IBM, where she served as Vice President, Global Talent Management, in addition to numerous executive roles driving HR policy across IBM’s multiple business units and geographies. Annette was born in San Juan, Puerto Rico and is fluent in Spanish. She holds an MS in Human Resources from the University of South Carolina and a BA in Psychology from the University of Georgia. Annette serves on West Chester University’s Presidential Board of Advisors.
Click here to learn more about the Women of Distinction Honorees on Philadelphia Business Journal’s website.
At West, we actively foster an inclusive and collaborative culture for our team members where different views and perspectives are welcomed and valued. We are convinced that this approach brings forth innovation, learning and growth for our team members on a global basis.
Research in the area of cell and gene therapies started almost 40 years ago, however recently there has been a surge of activity including landmark regulatory approvals for therapies treating chronic and rare diseases. In 2017 and 2018 the FDA approved the first two CART-T cell therapies for cancer treatment and the first two gene therapies for rare diseases. All four of these cell and gene therapies were approved under the FDA Accelerated Approval Program, aimed at expediting approvals for life saving drug therapies. These regulatory programs have the potential to shorten drug development as much as 1-3 years. Currently, there are more than 1,000 regenerative medicine clinical trials underway globally<sup>1</sup>, and the market is expected to grow rapidly over the next 10+ years.
In September 2023, Dr. Bettine Boltres, West’s contact for scientific affairs and technical solutions for glass, shared with us the most frequently asked questions that she encounters on glass-related topics. We are pleased to share Part 2 of the series where Dr. Boltres will share the remainder of the 10 most common questions she gets asked concerning glass vials.<br />You can read Part 1 of the series <a href="/blog/2023/september/frequently-asked-questions-challenges-glass-vial-packaging-solutions">here</a>.
On December 1, 2013, revisions to USP Ch. <1> Injections, Labeling on Ferrules and Cap Overseals will go into effect for all drug products sold in the United States, including veterinary products. Now is the time to ensure that your product packaging is compliant.
My name is Michele Polinsky and I am a breast cancer survivor.<br />These days it’s the simple things that make me happy. Watching my daughter play soccer at Virginia Tech, taking my son to high school and watching his soccer games. Celebrating holidays and birthdays. Simple things that you take for granted when you are healthy. And you start to worry won’t be in your future when you are first diagnosed with cancer. It’s a scary time.
English
Chinese
